1-5 of 5
Angel F. Lopez, MBBS, PhD
Close
Sort by
Journal Articles

Accumulation of JAK Activation-Loop Phosphorylation Promotes Type I JAK Inhibitor Withdrawal Syndrome in Myelofibrosis

Denis Tvorogov, PhD, Daniel Thomas, MD PhD, Nicholas P.D Liau, Mara Dottore, Emma F Barry, Maya Lathi, Winnie L Kan, PhD, Tim R Hercus, PhD, Frank Stomski, PhD, Timothy P. Hughes, MDMBBS,FRACP,FRCPA, Vinay Tergaonkar, PhD, Michael W Parker, PhD, David M Ross, Jeffrey J Babon, PhD, Ravindra Majeti, MD PhD, Angel F. Lopez, MBBS,PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1787.
https://doi.org/10.1182/blood-2018-99-115760
Published: 2018
Journal Articles

IL3-Receptor Signaling Is Dispensable For The Generation and Maintenance Of Jak2V617F-Induced Myeloproliferative Neoplasm (MPN

Therese Vu, Claudia Bruedigam, Rebecca Austin, Catherine Paine-Kuhn, Hayley S. Ramshaw, PhD, Angel F. Lopez, MBBS, PhD, Geoff Hill, MD, Ann Mullally, MD, Steven W Lane, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2841.
https://doi.org/10.1182/blood.V122.21.2841.2841
Published: 2013
Journal Articles

Effective Elimination of CML Progenitor and Stem Cells Through Combination of α-CD123 Antibody-Dependent Cell-Mediated Cytotoxicity and Tyrosine Kinase Inhibitor Treatment

Eva Nievergall, PhD, Deborah L. White, PhD, FFSc(RCPA), Agnes S.M. Yong, MD, PhD, Hayley S. Ramshaw, PhD, Samantha J. Busfield, PhD, Gino Vairo, PhD, Angel F. Lopez, MBBS, PhD, Timothy P. Hughes, MD, MBBS, Devendra K. Hiwase, MBBS, MD, PhD, FRACP, FRCPA
Journal: Blood
Blood (2012) 120 (21): 32.
https://doi.org/10.1182/blood.V120.21.32.32
Published: 2012
Journal Articles

CSL362: A Monoclonal Antibody to Human Interleukin-3 Receptor (CD123), Optimized for NK Cell-Mediated Cytotoxicity of AML Stem Cells

Samantha J. Busfield, PhD, Mark Biondo, PhD, Mae Wong, PhD, Hayley S. Ramshaw, PhD, Erwin M Lee, PhD, Kirstee Martin, PhD, Souravi Ghosh, PhD, Hal Braley, Vesna Tomasetig, Con Panousis, PhD, Gino Vairo, PhD, Andrew W. Roberts, MBBS, PhD, Simon Z. He, MBBS, Naomi Sprigg, Daniel Thomas, MBBS, PhD, Mark DeWitte, VMD, Richard B. Lock, PhD, Angel F. Lopez, MBBS, PhD, Andrew Nash, PhD
Journal: Blood
Blood (2012) 120 (21): 3598.
https://doi.org/10.1182/blood.V120.21.3598.3598
Published: 2012
Journal Articles

Antibody-Targeting of IL-3 Receptor-α Increases the Susceptibility of CD34 + CML Progenitors to Dasatinib-Induced Cell Death,

Eva Nievergall, Deborah L. White, PhD. FFSc(RCPA), Hayley Ramshaw, PhD, Angel F. Lopez, MBBS, PhD, Timothy P. Hughes, MD, MBBS, Devendra K Hiwase, MBBS, MD, PhD, FRACP, FRCPA
Journal: Blood
Blood (2011) 118 (21): 3745.
https://doi.org/10.1182/blood.V118.21.3745.3745
Published: 2011